Therefore, having clearly laid out the evidence for ADA deficiency as a multi-organ system disease, it is important to further investigate the mechanisms underlying the different organ manifestations in order to improve existing treatments and allow a more complete correction. The gene discussed is ADA; the disease is hyperinsulinemic hypoglycemia, familial, 4.